Literature DB >> 4555924

Non-specific and specific immunotherapy in patients with melanoma.

H F Seigler, W W Shingleton, R S Metzgar, C E Buckley, P M Bergoc, D S Miller, B F Fetter, M B Phaup.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4555924

Source DB:  PubMed          Journal:  Surgery        ISSN： 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  13 in total

Review 1.  The role of immunotherapy in the management of patients with malignant melanoma.

Authors:  J E Goodnight; D L Morton
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

2.  Immunotherapy in patients with melanoma.

Authors:  H F Seiger; W W Shingleton; R S Metzgar; C E Buckley
Journal:  Ann Surg       Date:  1973-09       Impact factor: 12.969

3.  Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis.

Authors:  Rebekah R White; Wilma E Stanley; Jeffrey L Johnson; Douglas S Tyler; Hilliard F Seigler
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

4.  Clinical value of immunochemotherapy with OK-432 or PS-K for stomach cancer patients.

Authors:  S Fujimoto; M Takahashi; T Minami; H Ishigami; M Miyazaki; K Itoh
Journal:  Jpn J Surg       Date:  1979-09

5.  Immunotherapy as an adjunct to surgery in the treatment of cancer.

Authors:  F R Eilber; E C Holmes; D L Morton
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

6.  Critical analysis of treatment of stage II and stage III melanoma patients with immunotherapy.

Authors:  W R Jewell; J H Thomas; J M Sterchi; P A Morse; L J Humphrey
Journal:  Ann Surg       Date:  1976-05       Impact factor: 12.969

7.  [Association between tumor immunology, stromal reaction, and tumor endocarditis (author's transl)].

Authors:  P Stosiek
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1975-12-31

8.  BCG immunotherapy of malignant melanoma: summary of a seven-year experience.

Authors:  D L Morton; F R Eilber; E C Holmes; J S Hunt; A S Ketcham; M J Silverstein; F C Sparks
Journal:  Ann Surg       Date:  1974-10       Impact factor: 12.969

9.  The presence and significance of the Thomsen-Friedenreich antigen in mammary gland. II. Its topochemistry in normal, hyperplastic and carcinoma tissue of the breast.

Authors:  P J Klein; R A Newman; P Müller; G Uhlenbruck; P Citoler; H E Schaefer; K J Lennartz; R Fischer
Journal:  J Cancer Res Clin Oncol       Date:  1979-02-19       Impact factor: 4.553

10.  Immunotherapy of Cancer with Nonliving BCG and Fractions Derived from Mycobacteria: Role of Cord Factor (Trehalose-6, 6'-Dimycolate) in Tumor Regression.

Authors:  A Bekierkunst; L Wang; R Toubiana; E Lederer
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.